Eosinophilic oesophagitis: Epidemiology, pathogenesis and management

Drugs

Volumn 71, Issue 5, 2011, Pages 527-540

  Remedios, Matthew ^a   Jones, Dianne ^b   Kerlin, Paul ^a  

^a WESLEY HOSPITAL   (Australia)

^b Logan Hospital   (Australia)

Author keywords

Azathioprine; Budesonide; Corticosteroids; Diet; Eosinophilic oesophagitis; Fluticasone propionate; Infliximab; Mepolizumab; Mercaptopurine; Methylprednisolone; Montelukast; Prednisone; Proton pump inhibitors; Research and development; Sodium cromoglicate; Surgery

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; MEPOLIZUMAB; MONTELUKAST; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ALLERGY; ANAMNESIS; ARTICLE; CORTICOSTEROID THERAPY; DIET THERAPY; DRUG EFFICACY; DYSPHAGIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; PATHOGENESIS; SEX RATIO; THORAX PAIN; VOMITING;

ADULT; AGE FACTORS; ALLERGENS; ANIMALS; CHILD; DILATATION; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MUCOUS MEMBRANE; PROTON PUMP INHIBITORS; SEX FACTORS;

EID: 79953211131     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11585450-000000000-00000     Document Type: Article

References (75)

1. Franciosi JP, Liacouris CA. Eosinophilic esophagitis. Immunol Allergy Clin N Am 2009; 29: 19-27.
2. Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic eso- phagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995; 109: 1503-12.
3. Teitelbaum JE, Fox VL, Twarog FJ, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002; 122: 1216-25. (Pubitemid 34465163)
4. Sgouros SN, Bergele C, Mantides A. Eosinophilic esopha- gitis in adults: a systematic review. Eur J Gastroenterol Hepatol 2006; 18: 211-7. (Pubitemid 43361608)
5. Remedios M, Campbell C, Jones DM, et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propio-nate. Gastrointest Endosc 2006; 63: 3-12. (Pubitemid 41827769)
6. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic eso- phagitis. N Engl J Med 2004; 351: 940-1.
7. Patel SM, Falchuk KR. Three brothers with dysphagia caused by eosinophilic esophagitis. Gastrointest Endosc 2005; 61 (1): 165-7. (Pubitemid 40169836)
8. Rothenberg ME, Spergel JM, Sherrill JD, et al. Common variants at 5q22 associate with pediatric eosinophilic eso-phagitis. Nat Genet 2010 Apr; 42 (4): 289-91.
9. Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al. Histo- pathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006; 64 (3): 313-9. (Pubitemid 44233586)
10. Simon D, Marti H, Heer P, et al. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol 2005; 115: 1090-2. (Pubitemid 40616230)
11. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3: 1198-206. (Pubitemid 41797671)
12. Prasad GA, Alexander JA, Schleck CD. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastro Hepatol 2009; 7: 1055-61.
13. Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003; 112: 796-7.
14. Onbasi K, Sin AZ, Doganavsargil B, et al. Eosinophil in- filtration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy 2005; 35: 1423-31.
15. Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosino-philic esophagitis in newly diagnosed children? J Clin Gastroenterol 2007; 41: 451-3. (Pubitemid 46642529)
16. Chehade M, Sampson HA. Epidemiology and etiology of eosinophilic esophagitis. Gastrointest Endoscopy Clin N Am 2008; 18: 33-44. (Pubitemid 350166934)
17. Cherian S, Smith NM, Forbes DA. Rapidly increasing prev- alence of eosinophilic oesophagitis in Western Australia. Arch Dis Child 2006; 91: 1000-4. (Pubitemid 44863138)
18. Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 2005; 115: 418-9.
19. Portmann S, Heer R, Bussmann C. Epidemiology of eosi- nophilic esophagitis: data from a community-based longitudinal study work carried out by the Swiss EE study group, Switzerland [abstract]. Gastroenterology 2007; 132: A609.
20. Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009; 137: 1238-49.
21. Fox VL, Nurko S, Teitelbaum JE, et al. High-resolution EUS in children with eosinophilic "allergic" esophagitis. Gastrointest Endosc 2003; 57: 30-6. (Pubitemid 36236795)
22. Stevoff C, Rao S, Parsons W, et al. EUS and histopathologic correlates in eosinophilic esophagitis. Gastrointest Endosc 2001; 54: 373-7. (Pubitemid 33665520)
23. Mishra A, Wang M, Pemmaraju VR, et al. Esophageal re- modeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 2008; 134: 204-14. (Pubitemid 350309313)
24. Liacouris CA. Pharmacologic treatment of eosinophilic esophagitis. Gastrointest Endoscopy Clin N Am 2008; 18: 169-78.
25. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342-63.
26. Yan BM, Shaffer EA. Primary eosinophilic disorders of the gastrointestinal tract. Gut 2009; 58: 721-32.
27. Orenstein SR, Shalaby TM, Di Lorenzo C, et al. The spec- trum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000; 95: 1422-30. (Pubitemid 30396298)
28. Walsh SV, Antonioli DA, Goldman H, et al. Allergic eso- phagitis in children: a clinicopathological entity. Am J Surg Pathol 1999; 23: 390-6. (Pubitemid 29159999)
29. Desai TK, Stecevic V, Chang CH, et al. Association of eo- sinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc 2005; 61: 795-801. (Pubitemid 40779406)
30. Kerlin P, Jones D, Remedios M, et al. Prevalence of eosi- nophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol 2007 Apr; 41 (4): 356-61. (Pubitemid 46573061)
31. Croese J, Fairley SK, Masson JW, et al. Clinical and en- doscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc 2003; 58 (4): 516-22. (Pubitemid 37205763)
32. Straumann A, Spichtin HP, Bucher KA, et al. Eosinophilic esophagitis: red on microscopy, white on endoscopy. Digestion 2004; 70 (2): 109-16. (Pubitemid 39370405)
33. Lim JR, Gupta SK, Croffie JM, et al. White specks in the esophageal mucosa: an endoscopic manifestation of non-reflux eosinophilic esophagitis in children. Gastrointest Endosc 2004; 59 (7): 835-8. (Pubitemid 38879311)
34. Vasilopoulos S, Murphy P, Auerbach A, et al. The small- caliber esophagus: an unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis. Gastro-intest Endosc 2002; 55 (1): 99-106. (Pubitemid 41122937)
35. Dahshan A, Rabah R. Correlation of endoscopy and his- tology in the Gastroesophageal mucosa in children: are routine biopsies justified? J Clin Gastroenterol 2000; 31: 213-6.
36. Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007; 102: 2627-32. (Pubitemid 350179332)
37. Straumann A, Bussmann C, Zuber M, et al. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol He-patol 2008; 6: 598-600.
38. Parfitt JR, Gregor JC, Suskin NG, et al. Eosinophilic eso- phagitis in adults: distinguishing features from gastroeso-phageal reflux disease: a study of 41 patients. Mod Pathol 2006; 19: 90-6. (Pubitemid 43250983)
39. Collins MH. Histopathologic features of eosinophilic esopha- gitis. Gastrointest Endoscopy Clin N Am 2008; 18: 59-71. (Pubitemid 350176667)
40. Arora AS, Yamazaki K. Eosinophilic esophagitis: asthma of the esophagus? Clin Gastroenterol Hepatol 2004; 2: 523-30. (Pubitemid 38834035)
41. Konikoff MR, Blanchard C, Kirby C, et al. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006; 4 (11): 1328-36. (Pubitemid 44716743)
42. Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005; 95 (4): 336-43. (Pubitemid 41483727)
43. Assa'ad AH, Putnam PE, Collins MH, et al Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 2007 119 731-8. (Pubitemid 46335818)
44. Spergel JM, Beausoleil JL, Mascarenhas M, et al. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002; 109: 363-8. (Pubitemid 34158307)
45. Spergel JM, Brown-Whitehorn T, Beausoleil JL, et al. Pre- dictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol 2007; 119: 509-11. (Pubitemid 46204823)
46. Assa'ad A. Detection of causative foods by skin prick and atopy patch tests in patients with eosinophilic esophagitis: things are not what they seem. Ann Allergy Asthma Immunol 2005; 95: 309-11.
47. Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six- food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006; 4 (9): 1097-102. (Pubitemid 44311644)
48. Gonsalves N, Yang G, Doerfler B, et al. A prospective clinical trial of six food elimination diet and reintroduction of causative agents in adults with eosinophilic esophagitis [abstract]. Gastroenterology 2008; 134: A104.
49. Markowitz JE, Spergel JM, Ruchelli E, et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 2003; 98: 777-82. (Pubitemid 36576301)
50. Schoepfer AM, Gschossmann J, Scheurer U, et al. Esopha- geal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids. Endoscopy 2008; 40: 161-4. (Pubitemid 351292221)
51. Cohen MS, Kaufman AB, Palazzo JP, et al. An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol 2007; 5: 1149-53. (Pubitemid 47488963)
52. Eisenbach C, Merle U, Schirmacher P, et al. Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy 2006; 38 Suppl. 2: E43-4.
53. Gonsalves N, Karmali K, Hirano I. Safety and response of esophageal dilation in adults with eosinophilic esophagitis [abstract]. Gastroenterology 2007; 132 Suppl. 2: T2034.
54. Dellon ES, Gibbs WB, Rubinas TC, et al. Esophageal dila- tion in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc 2010 Apr; 71 (4): 706-12.
55. Dohil R, Newbury R, Fox L, et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010; 139: 418-29.
56. Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepa-tol 2011 Feb; 9 (2): 110-7.
57. Liacouras CA, Wenner W, Voytek T, et al. Primary eosi- nophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998; 26 (4): 380-5. (Pubitemid 28160684)
58. Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol 2008; 6 (2): 165-73. (Pubitemid 351172942)
59. Faubion Jr W, Perrault J, Burgart LJ, et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998; 27 (1): 90-3. (Pubitemid 28293032)
60. Arora AS, Perrault J, Smyrk TC. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc 2003; 78: 830-5. (Pubitemid 36759291)
61. Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone pro-prionate for pediatric eosinophilic esophagitis. Gastro-enterology 2006; 131 (5): 1381-91. (Pubitemid 44780861)
62. Noel RJ, Putnam PE, Collins MH, et al. Clinical and im- munopathologic effects of swallowed fluticasone for eosi-nophilic esophagitis. Clin Gastroenterol Hepatol 2004; 2 (7): 568-75. (Pubitemid 38834041)
63. Aceves SS, Bastian JF, Newbury RO, et al. Oral viscous budesonide: a potential new therapy for eosinophilic eso-phagitis in children. Am J Gastroenterol 2007; 102 (10): 2271-9. (Pubitemid 47493832)
64. Aceves SS, Dohil R, Newbury RO, et al. Topical viscous budesonide suspension for treatment of eosinophilic eso-phagitis [letter]. J Allergy Clin Immunol 2005; 116 (3): 5-6.
65. Straumann ADL, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosi-nophilic esophagitis. Gastroenterology 2010; 139: 1526-37.
66. Lindberg GM, Van Eldik R, Saboorian MH. A case of herpes esophagitis after fluticasone propionate for eosino-philic esophagitis. Nat Clin Pract Gastroenterol Hepatol 2008 Sep; 5 (9): 527-30.
67. Gawrieh S, Shaker R. Treatment options for eosinophilic esophagitis: montelukast. Curr Gastroenterol Rep 2004; 6 (3): 190.
68. Sinharay R. Eosinophilic oesophagitis: treatment using montelukast. Gut 2003; 52 (8): 1228-9. (Pubitemid 36877445)
69. Attwood SE, Lewis CJ, Bronder CS, et al. Eosinophilic oesophagitis: a novel treatment using montelukast. Gut 2003; 52 (2): 181-5. (Pubitemid 36115056)
70. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563. Drugs R D 2008; 9 (2): 125-30.
71. Garrett JK, Jameson SC, Thomson B,etal. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004; 113: 115-9. (Pubitemid 38096170)
72. Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006 Dec; 118 (6): 1312-9. (Pubitemid 44872890)
73. Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut 2010 Jan; 59 (1): 21-30.
74. Straumann A, Bussmann C, Conus S, et al. Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esopha-gitis. J Allergy Clin Immunol 2008; 122: 425-7.
75. Netzer P, Gschossmann JM, Straumann A, et al. Cortico- steroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol 2007; 19: 865-9 (Pubitemid 47415145)